Screener
McKesson MCK Medical-Surgical Solutions — Foreign currency translation adjustments, net
Other segment segments
Similar metrics at other companies
Other financials
Where this comes from
Reported directly by McKesson in its filing.
Tagged under the XBRL concept us-gaap:GoodwillForeignCurrencyTranslationGainLoss.
The source filing: McKesson’s 10-Q, filed August 5, 2026.
- Filed
- Aug 5, 2026, 5:29 PM EDT
- Fiscal quarter
- Q1 FY2027
- Calendar quarter
- Q2 2026
- Accession
- 0000927653-26-000234
| (In millions) | North American Pharmaceutical | Oncology & Multispecialty | Prescription Technology Solutions | Medical-Surgical Solutions | Total |
|---|---|---|---|---|---|
| Balance, March 31, 2026 | $2,781 | $3,963 | $2,065 | $2,507 | $11,316 |
| Goodwill acquired | — | 13 | — | — | 13 |
| Disposals | — | (2) | — | — | (2) |
| Foreign currency translation adjustments, net | (26) | — | — | — | (26) |
| Other adjustments (1) | — | (23) | — | — | (23) |
| Balance, June 30, 2026 | $2,755 | $3,951 | $2,065 | $2,507 | $11,278 |
Item 1. Condensed Consolidated Financial Statements.
FAQ
- What is McKesson's medical-surgical solutions — foreign currency translation adjustments, net?
- McKesson (MCK) reported medical-surgical solutions — foreign currency translation adjustments, net of $0 in Q2 2026.
- What does medical-surgical solutions — foreign currency translation adjustments, net mean?
- Captures the net impact of fluctuations in foreign exchange rates on the financial results of the Medical-Surgical Solutions segment. This metric reflects the translation of international subsidiary financial statements into the reporting currency. It highlights the segment's exposure to global currency volatility outside of its primary domestic market.
Ask your AI about McKesson's medical-surgical solutions — foreign currency translation adjustments, net.
Connect your AI assistant and compare segments, right in your chat.
Connect your AI
Claude